Category: Joint ventures/collaborations
-
Regeneron, Children’s National Partner on Rare Diseases
Regeneron Genetics Center and Children’s National Health System have begun studying thousands of genetic profiles to better understand the causes of rare and undiagnosed disorders.
-
Partnership Assessing Nerve Stimulation Bleeding Device
The Feinstein Institute for Medical Research and Global Good Fund are evaluating an electronic device that stimulates nerves to stop bleeding, as a way to control postpartum hemorrhage
-
Algae Feed Proposed to Enrich Farm Salmon Fatty Acids
A developer of feeds for farmed salmon says its algae-based feed supplements could arrest the sharp decline in omega-3 fatty acids discovered in a recent study.
-
Trial Shows Antibody Reduces Days with Migraines
First results from a late-stage clinical trial shows a synthetic antibody reduces the number of days with migraines per month among people with episodic or infrequent migraines.
-
Oxford, Evotec Partner on Drug Discovery
A collaboration between University of Oxford and a German drug discovery company aims to speed promising new treatments to the market, including support for start-up enterprises.
-
Liquid Biopsy Lab to Reside at Cancer Institute
A designer of liquid biopsy tests to diagnose cancer is establishing a lab to study circulating tumor cells at John Wayne Cancer Institute in Santa Monica, California.
-
Crowdfunded Digital Health Investment Fund Launches
An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies.
-
Lilly, Institute Partner on Tuberculosis Drug Discovery
Drug maker Eli Lilly and Company is continuing its collaboration with Infectious Disease Research Institute to discovery new drugs that treat tuberculosis.
-
Health Insurance Group Forms Academic Research Network
The national organization of Blue Cross-Blue Shield health insurance providers is linking up with academic researchers to study outcomes of health care practices, including opioid abuse and cancer screenings.
-
Synthetic Virus Created to Treat Cancer in Dogs
Two companies partnering with Auburn University developed a synthetic virus to find and destroy tumor cells in a type of bone cancer in dogs.